Advagene Biopharma Co (ROCO:6709) Days Payable : 0.00 (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Advagene Biopharma Co Days Payable?

Advagene Biopharma Co's average Accounts Payable for the six months ended in Jun. 2024 was NT$0.00 Mil. Advagene Biopharma Co's Cost of Goods Sold for the six months ended in Jun. 2024 was NT$0.00 Mil.

The historical rank and industry rank for Advagene Biopharma Co's Days Payable or its related term are showing as below:

ROCO:6709's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 135.97
* Ranked among companies with meaningful Days Payable only.

Advagene Biopharma Co's Days Payable stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00).

Advagene Biopharma Co Days Payable Historical Data

The historical data trend for Advagene Biopharma Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advagene Biopharma Co Days Payable Chart

Advagene Biopharma Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

Advagene Biopharma Co Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Payable	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of Advagene Biopharma Co's Days Payable

For the Biotechnology subindustry, Advagene Biopharma Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advagene Biopharma Co's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advagene Biopharma Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Advagene Biopharma Co's Days Payable falls into.

Advagene Biopharma Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Advagene Biopharma Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Advagene Biopharma Co's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 2
=	0					/	0	*	365 / 2
=	N/A

Advagene Biopharma Co Days Payable Related Terms

Thank you for viewing the detailed overview of Advagene Biopharma Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Advagene Biopharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advagene Biopharma Co Ltd (ROCO:6709) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sector 1, Neihu Road, 6 Floor, No.308, Neihu District, Taipei, TWN, 114

Website

http://www.advagene.com.tw

Advagene Biopharma Co Ltd is a Taiwan based immune-modulatory platform-based drug developer. The company has completed technology transfer with DCB for detoxified LT Adjuvant Technology Platform. Its product development includes nasal spray influenza vaccine (LT-Flu), allergy vaccines (LT-Allergy), and other vaccines.

Advagene Biopharma Co Headlines

No Headlines